Comparison of careHPV and hybrid capture 2 assays for detection of high-risk human Papillomavirus DNA in cervical samples from hiv-1-infected African women

Journal of Clinical Microbiology

Volumn 51, Issue 12, 2013, Pages 4240-4242

  Ngou, Jean ^a   Magooa, Mahlape P ^b   Gilham, Clare ^c   Djigma, Florencia ^d   Didelot, Marie Noelle ^a   Kelly, Helen ^c   Yonli, Albert ^d   Sawadogo, Bernard ^e   Lewis, David A ^b,f   Delany Moretlwe, Sinead ^g,h   Mayaud, Philippe ^c   Segondy, Michel ^a  

^a MONTPELLIER UNIVERSITY HOSPITAL   (France)

^b NATIONAL INSTITUTE FOR COMMUNICABLE DISEASES   (South Africa)

^c LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^d Centre de Recherche Biomolé Culaire Pietro Annigoni   (Burkina Faso)

^e UNIVERSITÉ DE OUAGADOUGOU   (Burkina Faso)

^f Faculty of Health Sciences   (South Africa)

^g Reproductive Health and HIV Research Unit   (South Africa)

^h UNIVERSITY OF THE WITWATERSRAND   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA;

ADULT; AFRICA; ARTICLE; ASSAY; CANCER SCREENING; CAREHPV ASSAY; CONTROLLED STUDY; DNA DETERMINATION; FEMALE; HIGH RISK HUMAN PAPILLOMAVIRUS; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HYBRID CAPTURE 2 ASSAY; INTERMETHOD COMPARISON; MIDDLE AGED; NONHUMAN; PRIORITY JOURNAL; UTERINE CERVIX; UTERINE CERVIX CANCER; VIRUS CULTURE; VIRUS DETECTION; WART VIRUS; YOUNG ADULT;

ADULT; AFRICA; CERVIX UTERI; DNA, VIRAL; EARLY DETECTION OF CANCER; FEMALE; HIV INFECTIONS; HUMANS; MIDDLE AGED; MOLECULAR DIAGNOSTIC TECHNIQUES; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; VIROLOGY;

EID: 84889875083     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.02144-13     Document Type: Article

References (11)

1. Denny L, Anorlu R. 2012. Cervical cancer in Africa. Cancer Epidemiol. Biomarkers Prev. 21:1434-1438.
2. Munoz N, Bosch FX, de Sanjosé S, Herrero R, Castellsagué X, Shah KV, Snijders PJ, Meijer CJ, International Agency for Research on Cancer Multicenter Cervical Cancer Study Group. 2003. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N. Engl. J. Med. 348:518-527.
3. Cuzick J, Clavel C, Petry KU, Meijer CJ, Hoyer H, Ratnam S, Szarewski A, Birembaut P, Kulasingam S, Sasieni P, Iftner T. 2006. Overview of the European and North American studies on HPV testing in primary cervical cancer screening. Int. J. Cancer 119:1095-1101.
4. Ronco G, Giorgi-Rossi P, Carozzi F, Confortini M, Dalla Palma P, Del Mistro A, Ghiringhello B, Girlando S, Gillio-Tos A, De Marco L, Naldoni C, Pierotti P, Rizzolo R, Schincaglia P, Zorzi M, Zappa M, Segnan N, Cuzick J. 2010. New Technologies for Cervical Cancer screening (NTCC) Working Group. Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trial. Lancet Oncol. 11:249-257.
5. Ahdieh L, Klein RS, Burk R, Cu-Uvin S, Schuman P, Duerr A, Safaeian M, Astemborski J, Daniel R, Shah K. 2001. Prevalence, incidence, and type-specific persistence of human papillomavirus in human immunodeficiency virus (HIV)-positive and HIV-negative women. J. Infect. Dis. 184:682-690.
6. Schuman P, Ohmit SE, Klein RS, Duerr A, Cu-Uvin S, Jamieson DJ, Anderson J, Shah KV, HIV Epidemiology Research Study (HERS) Group. 2003. Longitudinal study of cervical squamous intraepithelial lesions in human immunodeficiency virus (HIV)-seropositive and at-risk HIV-seronegative women. J. Infect. Dis. 188:128-136.
7. Strickler HD, Burk RD, Fazzari M, Anastos K, Minkoff H, Massad LS, Hall C, Bacon M, Levine AM, Watts DH, Silverberg MJ, Xue X, Schlecht NF, Melnick S, Palefsky JM. 2005. Natural history and possible reactivation of human papillomavirus in human immunodeficiency virus- positive women. J. Natl. Cancer Inst. 97:577-586.
8. Qiao YL, Sellors JW, Eder PS, Bao YP, Lim JM, Zhao FH, Weigl B, Zhang WH, Peck RB, Li L, Chen F, Pan QJ, Lorincz AT. 2008. A new HPV-DNA test for cervical-cancer screening in developing regions: a cross-sectional study of clinical accuracy in rural China. Lancet Oncol. 9:929-936.
9. Gage JC, Ajenifuja KO, Wentzensen N, Adepiti AC, Stoler M, Eder PS, Bell L, Shrestha N, Eklund C, Reilly M, Hutchinson M, Wa- cholder S, Castle PE, Burk RD, Schiffman M. 2012. Effectiveness of a simple rapid human papillomavirus DNA test in rural Nigeria. Int. J. Cancer 131:2903-2909.
10. Didelot-Rousseau MN, Nagot N, Costes-Martineau V, Valles X, Ouedraogo A, Konate I, Weiss HA, Van de Perre P, Mayaud P, Segondy M, Yerelon Study Group. 2006. Human papillomavirus genotype distribution and cervical squamous intraepithelial lesions among high-risk women with and without HIV-1 infection in Burkina Faso. Br. J. Cancer 95:355-362.
11. Castle PE, Solomon D, Wheeler CM, Gravitt PE, Wacholder S, Schiffman M. 2008. Human papillomavirus genotype specificity of hybrid capture 2. J. Clin. Microbiol. 46:2595-2604.